Didanosine and Hemiparesis - a phase IV clinical study of FDA data

Summary:

Hemiparesis is found among people who take Didanosine, especially for people who are male, 40-49 old, have been taking the drug for 1 - 6 months.

The phase IV clinical study analyzes which people take Didanosine and have Hemiparesis. It is created by eHealthMe based on reports of 7,229 people who have side effects when taking Didanosine from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Jan, 27, 2023

7,229 people reported to have side effects when taking Didanosine.
Among them, 15 people (0.21%) have Hemiparesis.

What is Didanosine?

Didanosine has active ingredients of didanosine. It is often used in hiv infection. eHealthMe is studying from 7,238 Didanosine users for its effectiveness, alternative drugs and more.

What is Hemiparesis?

Hemiparesis (weakness on one side of the body) is found to be associated with 1,982 drugs and 1,398 conditions by eHealthMe.

Number of Didanosine and Hemiparesis reports submitted per year:

Time on Didanosine when people have Hemiparesis *:

Gender of people who have Hemiparesis when taking Didanosine *:

female: 46.67 %
male: 53.33 %

Age of people who have Hemiparesis when taking Didanosine *:

Common drugs people take besides Didanosine *:

Common side effects people have besides Hemiparesis *:

Speech Impairment (Adult) (inability to speak (adult)): 7 people, 46.67%
Cerebellar Syndrome (impaired blood circulation to cerebellum due to lesion in artery): 5 people, 33.33%
Fever: 5 people, 33.33%
Immune Reconstitution Syndrome (immune recovery syndrome): 4 people, 26.67%
Nausea (feeling of having an urge to vomit): 4 people, 26.67%
Diarrhea: 4 people, 26.67%
Nausea And Vomiting: 4 people, 26.67%
Haemoglobin Decreased: 4 people, 26.67%
Decreased Vibratory Sense: 3 people, 20.00%
Hypoaesthesia (reduced sense of touch or sensation): 3 people, 20.00%

Common conditions people have *:

Thrombocytopenia (decrease of platelets in blood): 1 person, 6.67%
Partial Seizures (seizures which affect only a part of the brain at onset): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Didanosine and have Hemiparesis?

Check whether Hemiparesis is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Hemiparesis and when was it recovered:

Hemiparesis in Didanosine

Expand to all the drugs that have ingredients of didanosine:

Hemiparesis and drugs with ingredients of didanosine

Alternative drugs to, pros and cons of Didanosine:

Didanosine (7,238 reports)

Common Didanosine side effects:

Fever: 511 reports
Lactic acidosis (low ph in body tissues): 342 reports
Abdominal pain: 328 reports
Diplopia (double vision): 291 reports

Browse all side effects of Didanosine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Hemiparesis treatments and more:

Hemiparesis (21,977 reports)

COVID vaccines that are related to Hemiparesis:

Common drugs associated with Hemiparesis:

All the drugs that are associated with Hemiparesis:

Hemiparesis (1,982 drugs)

Common conditions associated with Hemiparesis:

Multiple sclerosis: 3,681 reports
High blood pressure: 1,296 reports
Atrial fibrillation/flutter: 970 reports
Pain: 606 reports
Relapsing-remitting multiple sclerosis: 589 reports

All the conditions that are associated with Hemiparesis:

Hemiparesis (1,398 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on didanosine (the active ingredients of Didanosine) and Didanosine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.